Cue Health, the once high-flying San Diego biotech supplying rapid COVID-19 test kits to the NBA and Google, is laying off all employees and shutting down on Friday. Cue’s closure comes a week after ...

Covid-19 test maker Cue Health went public on Friday at a valuation of nearly $2.3 billion. Shares opened above the $16 price set the night before and closed at $20—a 25% increase in the first day of ...

In case you missed it, this commercial for Cue COVID tests made its debut during the Super Bowl. Cue lab-quality COVID-19 tests are at-home, molecular tests that need no prescription or special ...

The U.S. Food and Drug Administration told consumers Monday to throw out any at-home COVID-19 tests made by San Diego biotech Cue Health, because they could give users false results. Early in the ...

SAN DIEGO, March 16, 2022 /PRNewswire/ -- Cue Health ("Cue") (Nasdaq: HLTH), the healthcare technology company behind the most accurate at-home COVID-19 test* in the U.S., today announced that its ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. There have been two separate times, over the last six months, when my ...

Beginning November 15th, Consumers Can Get Cue's Fast and Accurate COVID-19 Tests, 24/7 Virtual Care, E-Prescription Services, and CDC-Compliant Test Results for Travel: Anywhere, Anytime SAN DIEGO, ...

COLUMBUS, Ohio--(BUSINESS WIRE)--Jet Edge, an innovative leader in full-service, private global aviation, today announced that it has entered into an agreement with Cue Health, a first of its kind in ...

It’s probably next to impossible to take an accurate gauge of the COVID-19 testing space. A look at Cue Health’s recent earnings and measures shows how the market is erratic. The San Diego, CA-based ...

Cue Health, a rapid diagnostics startup now working on a connected testing device, has closed $100 million in a Series C round announced this morning. Decheng Capital, Foresite Capital, Madrone ...